In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 34724398.
- Also identified by DOI 10.7326/ACPJ202111160-125.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. <b>Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis.</b> JAMA. 2021;326:499-518. 34228774.
Medical subject headings
- COVID-19 Drug Treatment